DTx Pharma To Participate In Upcoming Virtual Investor Conferences
SAN DIEGO–(BUSINESS WIRE)–DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease, announced today that Arthur T. Suckow, Ph.D., Chief Executive…